Neuroscience research
Pioneering genomics and AI-based study of the brain and how it affects behavior and cognitive functions
Our research team
POD Health's research team includes Bio-Scientists, Clinical Neurologists, Psychiatrists, educators and AI pioneers. The team is driving clinical trials with a real-time research approach enabled by a genomics and AI-based platform to continuously track and learn variations in behavior based on different drug regimens and therapy combinations. The goal of our research team is to drive precision medicine, best practices in Neurology and Psychiatry clinical practices, improve child health outcomes, lower cost of care and drive positive patient-doctor relationships.
Mohammed Farooq
Dilip Karnik, MD
Dr. Debarka Sengupta
Robert Dobyns, MD
Progress tracking
POD Health is designing and conducting customized clinical trials to understand the effectiveness of treatment plans for different child cohorts while carefully factoring in the overall environmental factors that effect the child.
The research data is automatically captured by our industry leading genomics and AI platform to drive inferences on baselining progress in every child. This drives population analytics to understand how similar children are responding to treatments.
All the latest research outcomes are available on the App for parents to track and compare their child's progress against similar children in the population.
Precision therapy recommendations
The wide-ranging clinical and etiological diversity within individuals affected by Autism Spectrum Disorder (ASD) and other neurological conditions in children has made precision medicine the most promising treatment approach.
POD Health is combining pathophysiologically based treatments with objective tests, known as stratification biomarkers, to predict which treatment might be most effective for a particular child.
Our team is tirelessly working on the development of cutting-edge algorithms that take into account clinical, pathological, genetic, and epigenetic parameters for patient stratification. This approach brings forth a new era of precision therapies, providing families and individuals with ASD and other conditions renewed hope for more targeted, effective treatments.
Precision treatment recommendations are delivered to parents, doctors and therapists in real-time through POD Health Genomics AI Platform and POD Health iPhone App.
Autism precision diagnosis: Extending the frontier
Autism, a complex genetic disorder, remains a perplexing enigma with over a hundred associated genes. Unfortunately, the lack of a concrete genetic diagnostic test for autism and related neurological disorders in children has left many questions unanswered.
However, on the horizon is an exhilarating breakthrough that promises to revolutionize our understanding of this condition. POD Health scientists are at the forefront of creating the most extensive genetic language models to unravel the intricate patterns of genetic alterations responsible for these disorders. The prospect of diagnosing autism through genetic insights is a beacon of hope, offering new avenues for early detection and tailored interventions.
POD Health scientists are working with clinical practitioners and gene testing labs like Genomind to drive precision diagnostic panels and deliver diagnostics directly through the POD Health platform to the POD Health for parents.